Delaware Street Drug Report
September 2026 | Report #2026-15
Approved: September 15, 2026
Contact: ORC@delaware.gov
Source: 2026.15 September Street Drug Report.final [2026.15 Se…port.final | PDF]
Disclaimer
This report is provided for educational and risk-mitigation purposes only. It is not intended for professional, clinical, legal, or publication use.
The data comes from limited drug residue testing conducted at various locations throughout Delaware. Results represent tested samples only and should not be assumed to reflect the entire drug supply.
Street drug stamp names are not standardized and may vary by location or supplier. The stamps listed below were collected from samples submitted during August 2026. [2026.15 Se…port.final | PDF]
August 2026 Sample Results
Drug Stamps and Compounds Detected
| Sample Stamp | Compounds Detected |
|---|---|
| Casamigos | Fentanyl, Medetomidine, Tetracaine |
| Good Time | 4-ANPP, Fentanyl, Medetomidine, Procaine, Tetracaine |
| Gucci | Fentanyl, Medetomidine, Tetracaine |
| KFC | Fentanyl, Medetomidine |
| Maria | 4-ANPP, Fentanyl, Medetomidine, Melatonin, Tetracaine |
| Super Sonic | Fentanyl, Medetomidine, Tetracaine |
| Uber | 4-ANPP, Fentanyl, Medetomidine, Procaine, Tetracaine |
| Windex Sample 1 | 4-ANPP, Cocaine, Fentanyl, Mannitol, Medetomidine |
| Windex Sample 2 | 4-ANPP, Fentanyl, Medetomidine |
| Used Device Sample 1 | 4-ANPP, Fentanyl, Lidocaine, Medetomidine, Phenethyl 4-ANPP, Procaine, Tetracaine |
| Used Device Sample 2 | Cocaine, Methamphetamine |
| Used Device Sample 3 | Benzoylecgonine, Cocaine, Fentanyl, Medetomidine, Phenacetin |
| Used Device Sample 4 | Cocaine, Medetomidine, Phenacetin |
| Used Device Sample 5 | Cocaine, Phenacetin |
Source data from August 2026 submissions. [2026.15 Se…port.final | PDF]
Substance Highlights
Phenacetin
Phenacetin is commonly used as an adulterant in cocaine and, more recently, some opioid supplies. Phenacetin is a known carcinogen, meaning it has been shown to cause cancer. It is also toxic to the kidneys and may damage the heart, blood, and urinary system. [2026.15 Se…port.final | PDF]
Medetomidine
Medetomidine is a veterinary tranquilizer that is not approved for human use. Similar to xylazine, it is considered more potent.
Reported adverse effects may include:
- Sedation
- Bradycardia (slow heart rate)
- Severe withdrawal symptoms
Cocaine
Cocaine is a stimulant classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA). It has a high potential for misuse and addiction.
Reported effects may include:
- Restlessness
- Paranoia
- Insomnia
- Loss of appetite
- Irregular heartbeat
- Seizures
Substance Trends
Percentage of Tested Samples Containing Each Substance
Sample Counts by Month
| Month | Samples Tested |
|---|---|
| March 2026 | 17 |
| April 2026 | 42 |
| May 2026 | 64 |
| June 2026 | 137 |
| July 2026 | 72 |
| August 2026 | 174 |
Detection Rates
| Compound Detected | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|
| Xylazine | 35% | 2% | 5% | 1% | 0% | 0% |
| Medetomidine | 65% | 21% | 36% | 24% | 15% | 20% |
| Fentanyl | 77% | 71% | 42% | 23% | 19% | 22% |
| Tetracaine | 24% | 43% | 27% | 20% | 11% | 11% |
| Procaine | 24% | 45% | 11% | 7% | 3% | 6% |
| Lidocaine | 6% | 2% | 9% | 4% | 1% | 4% |
| 4-ANPP | 41% | 29% | 11% | 8% | 4% | 8% |
| BTMPS | 0% | 0% | 0% | 0% | 1% | 0% |
| Fluorofentanyl | 0% | 0% | 0% | 0% | 6% | 0% |
| Cocaine | 29% | 37% | 56% | 70% | 78% | 53% |
| Methamphetamine | 18% | 7% | 6% | 3% | 1% | 9% |
| Pregabalin | 0% | 0% | 0% | 0% | 0% | 0% |
| Heroin | 0% | 2% | 0% | 1% | 0% | 0% |
| Carfentanil | 0% | 0% | 0% | 0% | 0% | 0% |
| Quinine | 0% | 2% | 0% | 1% | 6% | 0% |
| Levamisole | 6% | 2% | 2% | 0% | 0% | 0% |
Key Findings
- Cocaine detections decreased for the first time since February 2026. However, a larger percentage of submitted samples contained no detectable compounds during this reporting period. [2026.15 Se…port.final | PDF]
- The prevalence of cocaine in testing results is influenced by the number of stimulant-related samples submitted and should not be interpreted as a general shift in the overall drug supply. [2026.15 Se…port.final | PDF]
- Consistent with the previous month, xylazine was not detected in any tested samples. [2026.15 Se…port.final | PDF]
Image Accessibility
Alternative Text for Monthly Trends Chart
Figure: Monthly Substance Detection Trends, March through August 2026
Line chart showing the percentage of tested samples containing xylazine, fentanyl, medetomidine, cocaine, and methamphetamine from March through August 2026. Cocaine increased from 29% in March to a peak of 78% in July before declining to 53% in August. Medetomidine decreased from 65% in March and stabilized near 20% by August. Fentanyl declined substantially from 77% in March to 22% in August. Xylazine steadily declined and reached 0% in July and August. Methamphetamine remained below 20% throughout the reporting period.